4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-25-000515
Chief Financial Officer bought 9,056 shares at $1.04 ($9,434)
From the SEC's structured data for this filing
Trades in this filing
Carter Robert Ross · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-26 | Purchase : show line 1 in the form | +9,056 | $1.04 | $9,434 | 39,407 | D |
| Open-market purchases · 9,056 sh · avg $1.04 · $9,434 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-26 | Purchase : show line 2 in the form Common Warrant | +4,528 | $0.13 | $566 | 4,528 | D |
Loading xslF345X05/ownership.xml…